[HTML] plos.org

[HTML][HTML] Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy

L Yan, Z Xing, Z Guo, Z Fang, W Jiao, X Guo, Z Xu… - PLoS …, 2013 - journals.plos.org
Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved
in the development and progression of prostate cancer and the ultimate failure of androgen …
被引用次数：13 相关文章

[引用][C] Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy

L Yan, Z Xing, Z Guo, Z Fang, W Jiao, X Guo… - PLoS …, 2013 - ui.adsabs.harvard.edu
Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after
Androgen Deprivation Therapy - NASA/ADS Now on home page ads icon ads Enable full ADS …
[HTML] nih.gov

[HTML][HTML] Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy

L Yan, Z Xing, Z Guo, Z Fang, W Jiao, X Guo, Z Xu… - PLOS …, 2013 - ncbi.nlm.nih.gov
Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved
in the development and progression of prostate cancer and the ultimate failure of androgen …
[PDF] psu.edu

[PDF][PDF] Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen

L Yan, Z Xing, Z Guo, Z Fang, W Jiao - 2013 - Citeseer
Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved
in the development and progression of prostate cancer and the ultimate failure of androgen …

Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy

L Yan, Z Xing, Z Guo, Z Fang, W Jiao, X Guo… - PloS …, 2013 - pubmed.ncbi.nlm.nih.gov
Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved
in the development and progression of prostate cancer and the ultimate failure of androgen …
[PDF] semanticscholar.org

[PDF][PDF] Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen

L Yan, Z Xing, Z Guo, Z Fang, W Jiao - 2013 - pdfs.semanticscholar.org
Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved
in the development and progression of prostate cancer and the ultimate failure of androgen …

Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen Deprivation Therapy

L Yan, Z Xing, Z Guo, Z Fang, W Jiao, X Guo, Z Xu… - PLoS ONE, 2013 - go.gale.com
Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved
in the development and progression of prostate cancer and the ultimate failure of androgen …

Somatostatin derivative (smsDX) targets cellular metabolism in prostate cancer cells after androgen deprivation therapy.

L Yan, Z Xing, Z Guo, Z Fang, W Jiao, X Guo, Z Xu… - Plos one, 2013 - europepmc.org
Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved
in the development and progression of prostate cancer and the ultimate failure of androgen …
[PDF] scienceopen.com

[PDF][PDF] Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen

L Yan, Z Xing, Z Guo, Z Fang, W Jiao - 2013 - scienceopen.com
Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved
in the development and progression of prostate cancer and the ultimate failure of androgen …
[PDF] researchgate.net

[PDF][PDF] Somatostatin Derivative (smsDX) Targets Cellular Metabolism in Prostate Cancer Cells after Androgen

L Yan, Z Xing, Z Guo, Z Fang, W Jiao - 2013 - researchgate.net
Cancer cell metabolism responsive to androgen deprivation therapy (ADT) may be involved
in the development and progression of prostate cancer and the ultimate failure of androgen …